Skip to main content
. 2015 Jan 7;21(1):124–131. doi: 10.3748/wjg.v21.i1.124

Table 1.

Randomized controlled trials included in the analysis[10-12,18]

RCT Year Treatment Endpoint Size Number of cysts per group Mean cyst size (cm) P < 0.05 Jadad Score
Khuroo et al[34] 1993 ALB flow diagram s PD vs ALB+ PD Echo P 33 10, 12, 11 9.2 ± 4.4; 10.8 ± 3; 8.8 ± 4.5 Yes 2
ALB + PD > ALB alone
Gil-Grande et al[7] 1993 ALB 1-3 mo vs PLB + S Viability 55 18, 18, 19 10.4 ± 4; 8.91 ± 4; 10.5 ± 5 Yes 5
ALB 3 mo > ALB 1 mo > no ALB
Khuroo et al[35] 1997 ALB + PD vs S alone Echo P 50 25, 25 8 ± 3; 9.1 ± 3 Yes 3
ALB + PD > S alone
Dziri et al[54] 1999 OP vs no OP Deep abscess 115 58, 57 50; 502 Yes 2
OP > no OP
Franchi et al[6] 1999 ALB vs MBZ Echo P 448 178, 440 - Yes 2
ALB > MBZ
Keshmiri et al[8] 2001 ALB vs PLB Echo P 29 49, 191 74.01 ± 130.79; 198.13 ± 403.711 Yes 4
ALB > PLB
Bildik et al[9] 2007 ALB 1-3 mo vs no ALB + S Viability 84 - - Yes 1
ALB 3 mo > no ALB
Yüksel et al[15] 2008 Radical S vs conservative Early recurrence; cavity complications 32 15, 17 7.8; 8.1 Yes 3
Radical > Conservative
Shams-Ul-Bari et al[29] 2011 ALB + S vs S alone Viability 72 36, 36 - Yes 3
ALB + S > S alone
1

Mean volume of cysts in cm3;

2

Median size of the cavity in cm2. Degenerative imaging changes assessed through echography. Viability: Viability of hydatid disease; Echo P: Echo pattern; S: Surgery; ALB: Albendazole; PD: Percutaneous drainage; PLB: Placebo.